<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:media="http://search.yahoo.com/mrss/">
  <channel>
    <title>CARLAT PUBLISHING</title>
    <description>The Carlat Report</description>
    <link>https://www.thecarlatreport.com/rss/articles</link>
    <item>
      <title>Topiramate (Eprontia, Qudexy XR, Topamax, Trokendi XR) Fact Sheet</title>
      <description>
        <![CDATA[<p><span style=" font-style: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; widows: 2; word-spacing: 0px; display: inline !important; float: none;">Naltrexone, an opioid antagonist, is the first-line medication for alcohol use disorder (AUD)—though it is also approved for opioid use disorder (OUD).</span></p><br><br>]]>
      </description>
      <pubDate>Tue, 21 Apr 2026 16:33:31 -0400</pubDate>
      <link>https://www.thecarlatreport.com/articles/6201-topiramate-eprontia-qudexy-xr-topamax-trokendi-xr-fact-sheet</link>
      <guid>http://www.thecarlatreport.com/articles/6201</guid>
    </item>
    <item>
      <title>Naltrexone (ReVia, Vivitrol) Fact Sheet</title>
      <description>
        <![CDATA[<p><span style=" font-style: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; widows: 2; word-spacing: 0px; display: inline !important; float: none;">Naltrexone, an opioid antagonist, is the first-line medication for alcohol use disorder (AUD)—though it is also approved for opioid use disorder (OUD).</span></p><br><br>]]>
      </description>
      <pubDate>Tue, 21 Apr 2026 16:33:31 -0400</pubDate>
      <link>https://www.thecarlatreport.com/articles/6200-naltrexone-revia-vivitrol-fact-sheet</link>
      <guid>http://www.thecarlatreport.com/articles/6200</guid>
    </item>
    <item>
      <title>Gabapentin (Gralise, Horizant, Neurontin) Fact Sheet</title>
      <description>
        <![CDATA[<p><span style=" font-style: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; widows: 2; word-spacing: 0px; display: inline !important; float: none;">Gabapentin is effective as an off-label medication to ease alcohol withdrawal symptoms and to reduce cravings over the long term in patients with alcohol use disorder (AUD).</span></p><br><br>]]>
      </description>
      <pubDate>Tue, 21 Apr 2026 16:33:31 -0400</pubDate>
      <link>https://www.thecarlatreport.com/articles/6199-gabapentin-gralise-horizant-neurontin-fact-sheet</link>
      <guid>http://www.thecarlatreport.com/articles/6199</guid>
    </item>
    <item>
      <title>Disulfiram (Antabuse) Fact Sheet</title>
      <description>
        <![CDATA[<p><span style=" font-style: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; widows: 2; word-spacing: 0px; display: inline !important; float: none;">Disulfiram is an aversive treatment, causing a buildup of ethanol’s metabolite acetaldehyde in the serum, which in turn causes symptoms such as flushing, dizziness, nausea, and vomiting if patient consumes alcohol.</span></p><br>]]>
      </description>
      <pubDate>Tue, 21 Apr 2026 16:33:31 -0400</pubDate>
      <link>https://www.thecarlatreport.com/articles/6198-disulfiram-antabuse-fact-sheet</link>
      <guid>http://www.thecarlatreport.com/articles/6198</guid>
    </item>
    <item>
      <title>Acamprosate (Campral) Fact Sheet [G]</title>
      <description>
        <![CDATA[<p><span style=" font-style: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; widows: 2; word-spacing: 0px; display: inline !important; float: none;">Acamprosate is best for maintaining abstinence in patients who have already quit drinking, but it can be helpful even after patients relapse. Naltrexone is the better choice for patients who are still drinking, since it is better at helping patients quit. Acamprosate is preferred over naltrexone in patients with hepatic impairment.</span></p>]]>
      </description>
      <pubDate>Tue, 21 Apr 2026 16:33:31 -0400</pubDate>
      <link>https://www.thecarlatreport.com/articles/5082-acamprosate-campral-fact-sheet-g</link>
      <guid>http://www.thecarlatreport.com/articles/5082</guid>
    </item>
    <item>
      <title>Lithium Goes Mainstream</title>
      <description>
        <![CDATA[<style type="text/css">
p.p1 {margin: 0.0px 0.0px 0.0px 0.0px; font: 12.0px Helvetica; color: #000000}
</style><p style="box-sizing: border-box; cursor: text; caret-color: rgb(108, 117, 125); font-style: normal; font-weight: 400; letter-spacing: normal; orphans: auto; text-align: left; widows: auto; word-spacing: 0px;"><style type="text/css">
p.p1 {margin: 0.0px 0.0px 0.0px 0.0px; font: 12.0px Helvetica; color: #000000}
</style><style type="text/css">
p.p1 {margin: 0.0px 0.0px 0.0px 0.0px; font: 12.0px Helvetica; color: #000000}
</style><style type="text/css">
p.p1 {margin: 0.0px 0.0px 0.0px 0.0px; font: 12.0px Helvetica; color: #000000}
</style><style type="text/css">
p.p1 {margin: 0.0px 0.0px 0.0px 0.0px; font: 12.0px Helvetica; color: #000000}
</style><style type="text/css">
p.p1 {margin: 0.0px 0.0px 0.0px 0.0px; font: 12.0px Helvetica; color: #000000}
</style><style type="text/css">
p.p1 {margin: 0.0px 0.0px 0.0px 0.0px; font: 12.0px Helvetica; color: #000000}
</style><style type="text/css">
p.p1 {margin: 0.0px 0.0px 0.0px 0.0px; font: 12.0px Helvetica; color: #000000}
</style><style type="text/css">
p.p1 {margin: 0.0px 0.0px 0.0px 0.0px; font: 12.0px Helvetica; color: #000000}
</style><style type="text/css">
p.p1 {margin: 0.0px 0.0px 0.0px 0.0px; font: 12.0px Helvetica; color: #000000}
</style></p><p style="box-sizing: border-box; cursor: text; caret-color: rgb(108, 117, 125); font-style: normal; font-weight: 400; letter-spacing: normal; orphans: auto; text-align: left; widows: auto; word-spacing: 0px;"><style type="text/css">
p.p1 {margin: 0.0px 0.0px 0.0px 0.0px; font: 12.0px Helvetica; color: #000000}
</style><style type="text/css">
p.p1 {margin: 0.0px 0.0px 0.0px 0.0px; font: 12.0px Helvetica; color: #000000}
</style><style type="text/css">
p.p1 {margin: 0.0px 0.0px 0.0px 0.0px; font: 12.0px Helvetica; color: #000000}
</style><style type="text/css">
p.p1 {margin: 0.0px 0.0px 0.0px 0.0px; font: 12.0px Helvetica; color: #000000}
</style><style type="text/css">
p.p1 {margin: 0.0px 0.0px 0.0px 0.0px; font: 12.0px Helvetica; color: #000000}
</style><style type="text/css">
p.p1 {margin: 0.0px 0.0px 0.0px 0.0px; font: 12.0px Helvetica; color: #000000}
</style><style type="text/css">
p.p1 {margin: 0.0px 0.0px 0.0px 0.0px; font: 12.0px Helvetica; color: #000000}
</style><style type="text/css">
p.p1 {margin: 0.0px 0.0px 0.0px 0.0px; font: 12.0px Helvetica; color: #000000}
</style></p><div style="caret-color: rgb(0, 0, 0); font-style: normal; font-weight: 400; letter-spacing: normal; orphans: auto; widows: auto; word-spacing: 0px; text-align: left;"><style type="text/css">
p.p1 {margin: 0.0px 0.0px 0.0px 0.0px; font: 12.0px Helvetica; color: #000000}
</style><style type="text/css">
p.p1 {margin: 0.0px 0.0px 0.0px 0.0px; font: 12.0px Helvetica; color: #000000}
</style>In the 1950s, a young Danish psychiatrist named Mogens Schou staked his career — and his family — on a mineral most of his colleagues dismissed as dangerous nonsense. This is the story of how lithium went from fringe curiosity to the gold standard for bipolar disorder, and the bitter scientific battle that nearly derailed it.</div><style type="text/css">
p.p1 {margin: 0.0px 0.0px 0.0px 0.0px; font: 12.0px Helvetica; color: #000000}
</style><style type="text/css">
p.p1 {margin: 0.0px 0.0px 0.0px 0.0px; font: 12.0px Helvetica; color: #000000}
</style><style type="text/css">
p.p1 {margin: 0.0px 0.0px 0.0px 0.0px; font: 12.0px Helvetica; color: #000000}
</style><style type="text/css">
p.p1 {margin: 0.0px 0.0px 0.0px 0.0px; font: 12.0px Helvetica; color: #000000}
</style>]]>
      </description>
      <pubDate>Mon, 20 Apr 2026 02:00:00 -0400</pubDate>
      <link>https://www.thecarlatreport.com/blogs/2-the-carlat-psychiatry-podcast/post/6152-lithium-goes-mainstream</link>
      <guid>http://www.thecarlatreport.com/blogs/2/post/6152</guid>
      <enclosure url="https://www.thecarlatreport.com/ext/resources/2026/04/19/shutterstock_2769345501.webp?t=1776665016" type="image/jpeg" length="242799"/>
    </item>
    <item>
      <title>Clinically Significant Drug Interactions</title>
      <description>
        <![CDATA[<p><span style=" font-style: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; widows: 2; word-spacing: 0px; display: inline !important; float: none;">Generally, when pressed for time, most clinicians will use one of the following online drug interaction checkers.</span></p>]]>
      </description>
      <pubDate>Sun, 19 Apr 2026 15:43:40 -0400</pubDate>
      <link>https://www.thecarlatreport.com/articles/5280-clinically-significant-drug-interactions</link>
      <guid>http://www.thecarlatreport.com/articles/5280</guid>
    </item>
    <item>
      <title>Are We Preparing Autistic Patients for Adulthood?
</title>
      <description>
        <![CDATA[<p><span style="caret-color: rgb(255, 255, 255); font-style: normal; font-weight: 400; letter-spacing: normal; orphans: auto; text-align: start; widows: auto; word-spacing: 0px; display: inline !important; float: none;">We support autistic children. We abandon autistic adults.&nbsp;</span></p><p><span style="caret-color: rgb(255, 255, 255); font-style: normal; font-weight: 400; letter-spacing: normal; orphans: auto; text-align: start; widows: auto; word-spacing: 0px; display: inline !important; float: none;"></span><span style="caret-color: rgb(255, 255, 255); font-style: normal; font-weight: 400; letter-spacing: normal; orphans: auto; text-align: start; widows: auto; word-spacing: 0px; display: inline !important; float: none;">In our latest Child Psychiatry Report, Mary Baker-Ericzen, research professor at San Diego State University and clinical psychologist at the Intricate Mind Institute, asks clinicians to consider a different question at every visit:</span><span style="caret-color: rgb(255, 255, 255); font-style: normal; font-weight: 400; letter-spacing: normal; orphans: auto; text-align: start; widows: auto; word-spacing: 0px; display: inline !important; float: none;">
</span><span style="caret-color: rgb(255, 255, 255); font-style: normal; font-weight: 400; letter-spacing: normal; orphans: auto; text-align: start; widows: auto; word-spacing: 0px; display: inline !important; float: none;">Is this patient building the skills they'll need when the system stops showing up for them?</span></p><br>]]>
      </description>
      <pubDate>Fri, 17 Apr 2026 18:00:00 -0400</pubDate>
      <link>https://www.thecarlatreport.com/blogs/1-the-carlat-psychiatry-blog/post/6048-are-we-preparing-autistic-patients-for-adulthood</link>
      <guid>http://www.thecarlatreport.com/blogs/1/post/6048</guid>
      <enclosure url="https://www.thecarlatreport.com/ext/resources/2026/04/17/1773072497189.webp?t=1776488595" type="image/jpeg" length="27645"/>
    </item>
    <item>
      <title>Atomoxetine (Strattera) Fact Sheet for Patients</title>
      <description>
        <![CDATA[<p>Atomoxetine treats attention-deficit/hyperactivity disorder (ADHD) in children, adolescents, and adults.</p><br>]]>
      </description>
      <pubDate>Fri, 17 Apr 2026 16:35:47 -0400</pubDate>
      <link>https://www.thecarlatreport.com/articles/6037-atomoxetine-strattera-fact-sheet-for-patients</link>
      <guid>http://www.thecarlatreport.com/articles/6037</guid>
    </item>
    <item>
      <title>Autism Spectrum Disorder</title>
      <description>
        <![CDATA[<p><span style=" font-style: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; widows: 2; word-spacing: 0px; display: inline !important; float: none;">Patients with autism spectrum disorder (ASD) may be admitted to inpatient units for a variety of reasons.</span></p>]]>
      </description>
      <pubDate>Fri, 17 Apr 2026 16:35:47 -0400</pubDate>
      <link>https://www.thecarlatreport.com/articles/5195-autism-spectrum-disorder</link>
      <guid>http://www.thecarlatreport.com/articles/5195</guid>
    </item>
    <item>
      <title>Borderline Personality Disorder: Diagnosis and Treatment</title>
      <description>
        <![CDATA[<p>Patients with borderline personality disorder (BPD) account for about 20% of psychiatric inpatients and can often present challenges on the unit. In this fact sheet, we describe a systematic approach to diagnosis.</p><br><br>]]>
      </description>
      <pubDate>Fri, 17 Apr 2026 15:35:32 -0400</pubDate>
      <link>https://www.thecarlatreport.com/articles/6092-borderline-personality-disorder-diagnosis-and-treatment</link>
      <guid>http://www.thecarlatreport.com/articles/6092</guid>
    </item>
    <item>
      <title>Overview of Personality Disorders</title>
      <description>
        <![CDATA[<p><span style=" font-style: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; widows: 2; word-spacing: 0px; display: inline !important; float: none;">Personality disorders (PDs) are enduring patterns of behavior, cognition, and emotional regulation that can complicate treatment and disrupt the therapeutic environment of the unit.&nbsp;</span></p><br><br>]]>
      </description>
      <pubDate>Fri, 17 Apr 2026 15:35:32 -0400</pubDate>
      <link>https://www.thecarlatreport.com/articles/6091-overview-of-personality-disorders</link>
      <guid>http://www.thecarlatreport.com/articles/6091</guid>
    </item>
    <item>
      <title>Transitioning to Outpatient Care—A Guide to National Mental Health Resources</title>
      <description>
        <![CDATA[<p><span style=" font-style: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; widows: 2; word-spacing: 0px; display: inline !important; float: none;">Providing patients with resources as they transition from inpatient psychiatric units to outpatient care is vital for their continued support and recovery.&nbsp;</span></p><br><br>]]>
      </description>
      <pubDate>Fri, 17 Apr 2026 15:35:32 -0400</pubDate>
      <link>https://www.thecarlatreport.com/articles/6019-transitioning-to-outpatient-carea-guide-to-national-mental-health-resources</link>
      <guid>http://www.thecarlatreport.com/articles/6019</guid>
    </item>
    <item>
      <title>Supportive Therapy in an Inpatient Psychiatric Hospital</title>
      <description>
        <![CDATA[<p>Supportive therapy is a psychotherapeutic approach focused on providing emotional and practical support and strengthening a patient's coping mechanisms.&nbsp;</p><br>]]>
      </description>
      <pubDate>Fri, 17 Apr 2026 15:35:32 -0400</pubDate>
      <link>https://www.thecarlatreport.com/articles/6018-supportive-therapy-in-an-inpatient-psychiatric-hospital</link>
      <guid>http://www.thecarlatreport.com/articles/6018</guid>
    </item>
    <item>
      <title>Coding and Billing Protocols</title>
      <description>
        <![CDATA[<p><span style=" font-style: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; widows: 2; word-spacing: 0px; display: inline !important; float: none;">Coding inpatient psychiatric visits is a way of briefly describing how much work you did and therefore how much money the insurance company should pay for the visit.&nbsp;</span></p>]]>
      </description>
      <pubDate>Fri, 17 Apr 2026 15:35:32 -0400</pubDate>
      <link>https://www.thecarlatreport.com/articles/5154-coding-and-billing-protocols</link>
      <guid>http://www.thecarlatreport.com/articles/5154</guid>
    </item>
    <item>
      <title>Rivastigmine (Exelon, Exelon Patch) Fact Sheet [G]</title>
      <description>
        <![CDATA[]]>
      </description>
      <pubDate>Fri, 17 Apr 2026 15:27:38 -0400</pubDate>
      <link>https://www.thecarlatreport.com/articles/5030-rivastigmine-exelon-exelon-patch-fact-sheet-g</link>
      <guid>http://www.thecarlatreport.com/articles/5030</guid>
    </item>
    <item>
      <title>Treating BPD Series, Episode 2: Transference-Focused Psychotherapy—From Splitting to Coherence with Frank Yeomans, MD, PhD</title>
      <description>
        <![CDATA[<p>
 In this episode, Dr. Frank Yeomans offers a deep dive into the theory and clinical practice of TFP as a treatment for Borderline Personality Disorder.<span style=" font-style: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: start; widows: 2; word-spacing: 0px; display: inline !important; float: none;"> </span></p>]]>
      </description>
      <pubDate>Thu, 16 Apr 2026 03:00:00 -0400</pubDate>
      <link>https://www.thecarlatreport.com/blogs/2-the-carlat-psychiatry-podcast/post/5977-treating-bpd-series-episode-2-transference-focused-psychotherapyfrom-splitting-to-coherence-with-frank-yeomans-md-phd</link>
      <guid>http://www.thecarlatreport.com/blogs/2/post/5977</guid>
      <enclosure url="https://www.thecarlatreport.com/ext/resources/2023/11/08/thumb/supportive-psychotherapy-Dalle-11082023.webp?t=1699479350" type="image/jpeg" length="20572"/>
    </item>
    <item>
      <title>Treating BPD Series, Episode 2: Transference-Focused Psychotherapy—From Splitting to Coherence with Frank Yeomans, MD, PhD
</title>
      <description>
        <![CDATA[<p>
 In this episode, Dr. Frank Yeomans offers a deep dive into the theory and clinical practice of TFP as a treatment for Borderline Personality Disorder.<span style=" font-style: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: start; widows: 2; word-spacing: 0px; display: inline !important; float: none;">&nbsp;</span></p>]]>
      </description>
      <pubDate>Tue, 14 Apr 2026 00:00:00 -0400</pubDate>
      <link>https://www.thecarlatreport.com/articles/5976-bpd-series-ep-2-transference-focused-psychotherapy</link>
      <guid>http://www.thecarlatreport.com/articles/5976</guid>
    </item>
    <item>
      <title>Lithium: From 7UP to Table Salt</title>
      <description>
        <![CDATA[<style type="text/css">
p.p1 {margin: 0.0px 0.0px 0.0px 0.0px; font: 12.0px Helvetica; color: #000000}
</style><p style="box-sizing: border-box; cursor: text; caret-color: rgb(108, 117, 125); font-style: normal; font-weight: 400; letter-spacing: normal; orphans: auto; text-align: left; widows: auto; word-spacing: 0px;"><style type="text/css">
p.p1 {margin: 0.0px 0.0px 0.0px 0.0px; font: 12.0px Helvetica; color: #000000}
</style><style type="text/css">
p.p1 {margin: 0.0px 0.0px 0.0px 0.0px; font: 12.0px Helvetica; color: #000000}
</style><style type="text/css">
p.p1 {margin: 0.0px 0.0px 0.0px 0.0px; font: 12.0px Helvetica; color: #000000}
</style><style type="text/css">
p.p1 {margin: 0.0px 0.0px 0.0px 0.0px; font: 12.0px Helvetica; color: #000000}
</style><style type="text/css">
p.p1 {margin: 0.0px 0.0px 0.0px 0.0px; font: 12.0px Helvetica; color: #000000}
</style><style type="text/css">
p.p1 {margin: 0.0px 0.0px 0.0px 0.0px; font: 12.0px Helvetica; color: #000000}
</style><style type="text/css">
p.p1 {margin: 0.0px 0.0px 0.0px 0.0px; font: 12.0px Helvetica; color: #000000}
</style><style type="text/css">
p.p1 {margin: 0.0px 0.0px 0.0px 0.0px; font: 12.0px Helvetica; color: #000000}
</style><style type="text/css">
p.p1 {margin: 0.0px 0.0px 0.0px 0.0px; font: 12.0px Helvetica; color: #000000}
</style></p><p style="box-sizing: border-box; cursor: text; caret-color: rgb(108, 117, 125); font-style: normal; font-weight: 400; letter-spacing: normal; orphans: auto; text-align: left; widows: auto; word-spacing: 0px;"><style type="text/css">
p.p1 {margin: 0.0px 0.0px 0.0px 0.0px; font: 12.0px Helvetica; color: #000000}
</style><style type="text/css">
p.p1 {margin: 0.0px 0.0px 0.0px 0.0px; font: 12.0px Helvetica; color: #000000}
</style><style type="text/css">
p.p1 {margin: 0.0px 0.0px 0.0px 0.0px; font: 12.0px Helvetica; color: #000000}
</style><style type="text/css">
p.p1 {margin: 0.0px 0.0px 0.0px 0.0px; font: 12.0px Helvetica; color: #000000}
</style><style type="text/css">
p.p1 {margin: 0.0px 0.0px 0.0px 0.0px; font: 12.0px Helvetica; color: #000000}
</style><style type="text/css">
p.p1 {margin: 0.0px 0.0px 0.0px 0.0px; font: 12.0px Helvetica; color: #000000}
</style><style type="text/css">
p.p1 {margin: 0.0px 0.0px 0.0px 0.0px; font: 12.0px Helvetica; color: #000000}
</style><style type="text/css">
p.p1 {margin: 0.0px 0.0px 0.0px 0.0px; font: 12.0px Helvetica; color: #000000}
</style></p><div style="caret-color: rgb(0, 0, 0); font-style: normal; font-weight: 400; letter-spacing: normal; orphans: auto; widows: auto; word-spacing: 0px; text-align: left;"><style type="text/css">
p.p1 {margin: 0.0px 0.0px 0.0px 0.0px; font: 12.0px Helvetica; color: #000000}
</style>Before lithium became a cornerstone of psychiatry, it was in soda, spa water, and salt shakers. Trace lithium’s journey from Victorian health fad to life-saving mood stabilizer, and discover why the uric acid theory that launched it may be making a comeback.</div><style type="text/css">
p.p1 {margin: 0.0px 0.0px 0.0px 0.0px; font: 12.0px Helvetica; color: #000000}
</style><style type="text/css">
p.p1 {margin: 0.0px 0.0px 0.0px 0.0px; font: 12.0px Helvetica; color: #000000}
</style><style type="text/css">
p.p1 {margin: 0.0px 0.0px 0.0px 0.0px; font: 12.0px Helvetica; color: #000000}
</style><style type="text/css">
p.p1 {margin: 0.0px 0.0px 0.0px 0.0px; font: 12.0px Helvetica; color: #000000}
</style>]]>
      </description>
      <pubDate>Mon, 13 Apr 2026 02:00:00 -0400</pubDate>
      <link>https://www.thecarlatreport.com/blogs/2-the-carlat-psychiatry-podcast/post/5925-lithium-from-7up-to-table-salt</link>
      <guid>http://www.thecarlatreport.com/blogs/2/post/5925</guid>
      <enclosure url="https://www.thecarlatreport.com/ext/resources/2026/04/12/shutterstock_2766290053.webp?t=1776060143" type="image/jpeg" length="229321"/>
    </item>
    <item>
      <title>A Dangerous Myth in Child Psychiatry
</title>
      <description>
        <![CDATA[<p>Autism doesn't protect against suicide. It hides it.&nbsp;</p>]]>
      </description>
      <pubDate>Sat, 11 Apr 2026 17:55:00 -0400</pubDate>
      <link>https://www.thecarlatreport.com/blogs/1-the-carlat-psychiatry-blog/post/5924-a-dangerous-myth-in-child-psychiatry</link>
      <guid>http://www.thecarlatreport.com/blogs/1/post/5924</guid>
      <enclosure url="https://www.thecarlatreport.com/ext/resources/2026/04/11/1773071509084.webp?t=1775955813" type="image/jpeg" length="25887"/>
    </item>
    <item>
      <title>When Autism Meets the Legal System: A Clinician’s Guide</title>
      <description>
        <![CDATA[<style type="text/css">
p.p1 {margin: 0.0px 0.0px 0.0px 0.0px; font: 12.0px Helvetica; color: #000000}
</style><p style="box-sizing: border-box; cursor: text; caret-color: rgb(108, 117, 125); font-style: normal; font-weight: 400; letter-spacing: normal; orphans: auto; text-align: left; widows: auto; word-spacing: 0px;"><style type="text/css">
p.p1 {margin: 0.0px 0.0px 0.0px 0.0px; font: 12.0px Helvetica; color: #000000}
</style><style type="text/css">
p.p1 {margin: 0.0px 0.0px 0.0px 0.0px; font: 12.0px Helvetica; color: #000000}
</style><style type="text/css">
p.p1 {margin: 0.0px 0.0px 0.0px 0.0px; font: 12.0px Helvetica; color: #000000}
</style><style type="text/css">
p.p1 {margin: 0.0px 0.0px 0.0px 0.0px; font: 12.0px Helvetica; color: #000000}
</style><style type="text/css">
p.p1 {margin: 0.0px 0.0px 0.0px 0.0px; font: 12.0px Helvetica; color: #000000}
</style><style type="text/css">
p.p1 {margin: 0.0px 0.0px 0.0px 0.0px; font: 12.0px Helvetica; color: #000000}
</style><style type="text/css">
p.p1 {margin: 0.0px 0.0px 0.0px 0.0px; font: 12.0px Helvetica; color: #000000}
</style><style type="text/css">
p.p1 {margin: 0.0px 0.0px 0.0px 0.0px; font: 12.0px Helvetica; color: #000000}
</style><style type="text/css">
p.p1 {margin: 0.0px 0.0px 0.0px 0.0px; font: 12.0px Helvetica; color: #000000}
</style></p><p style="box-sizing: border-box; cursor: text; caret-color: rgb(108, 117, 125); font-style: normal; font-weight: 400; letter-spacing: normal; orphans: auto; text-align: left; widows: auto; word-spacing: 0px;"><style type="text/css">
p.p1 {margin: 0.0px 0.0px 0.0px 0.0px; font: 12.0px Helvetica; color: #000000}
</style><style type="text/css">
p.p1 {margin: 0.0px 0.0px 0.0px 0.0px; font: 12.0px Helvetica; color: #000000}
</style><style type="text/css">
p.p1 {margin: 0.0px 0.0px 0.0px 0.0px; font: 12.0px Helvetica; color: #000000}
</style><style type="text/css">
p.p1 {margin: 0.0px 0.0px 0.0px 0.0px; font: 12.0px Helvetica; color: #000000}
</style><style type="text/css">
p.p1 {margin: 0.0px 0.0px 0.0px 0.0px; font: 12.0px Helvetica; color: #000000}
</style><style type="text/css">
p.p1 {margin: 0.0px 0.0px 0.0px 0.0px; font: 12.0px Helvetica; color: #000000}
</style><style type="text/css">
p.p1 {margin: 0.0px 0.0px 0.0px 0.0px; font: 12.0px Helvetica; color: #000000}
</style><style type="text/css">
p.p1 {margin: 0.0px 0.0px 0.0px 0.0px; font: 12.0px Helvetica; color: #000000}
</style></p><div style="caret-color: rgb(0, 0, 0); font-style: normal; font-weight: 400; letter-spacing: normal; orphans: auto; widows: auto; word-spacing: 0px; text-align: left;">Legal questions come up in clinical care of autistic children and adults more often than many of us expect. A parent asks for a custody letter; a school requests documentation for services; a patient asks about disability benefits or driving. When autistic patients face legal systems, clinicians can help, but only if we stay within our role.</div><style type="text/css">
p.p1 {margin: 0.0px 0.0px 0.0px 0.0px; font: 12.0px Helvetica; color: #000000}
</style><style type="text/css">
p.p1 {margin: 0.0px 0.0px 0.0px 0.0px; font: 12.0px Helvetica; color: #000000}
</style><style type="text/css">
p.p1 {margin: 0.0px 0.0px 0.0px 0.0px; font: 12.0px Helvetica; color: #000000}
</style><style type="text/css">
p.p1 {margin: 0.0px 0.0px 0.0px 0.0px; font: 12.0px Helvetica; color: #000000}
</style>]]>
      </description>
      <pubDate>Mon, 06 Apr 2026 02:00:00 -0400</pubDate>
      <link>https://www.thecarlatreport.com/blogs/2-the-carlat-psychiatry-podcast/post/5904-when-autism-meets-the-legal-system-a-clinicians-guide</link>
      <guid>http://www.thecarlatreport.com/blogs/2/post/5904</guid>
      <enclosure url="https://www.thecarlatreport.com/ext/resources/2026/04/04/PodcastImage56978.webp?t=1775465229" type="image/jpeg" length="180358"/>
    </item>
    <item>
      <title>The Side Effects that Quietly Destroy Teeth </title>
      <description>
        <![CDATA[<p><span style="caret-color: rgb(255, 255, 255); font-style: normal; font-weight: 400; letter-spacing: normal; orphans: auto; text-align: start; widows: auto; word-spacing: 0px; display: inline !important; float: none;">It's easy to treat xerostomia as a nuisance, low on the priority list when you're managing psychosis or depression. But left unaddressed, it quietly does real damage.</span></p><br>]]>
      </description>
      <pubDate>Fri, 03 Apr 2026 17:55:00 -0400</pubDate>
      <link>https://www.thecarlatreport.com/blogs/1-the-carlat-psychiatry-blog/post/5903-the-side-effects-that-quietly-destroy-teeth</link>
      <guid>http://www.thecarlatreport.com/blogs/1/post/5903</guid>
      <enclosure url="https://www.thecarlatreport.com/ext/resources/2026/04/03/1771503682873.webp?t=1775264653" type="image/jpeg" length="59191"/>
    </item>
    <item>
      <title>Learning Objectives, PTSD, TCPR, April 2026</title>
      <description>
        <![CDATA[<p><em style="box-sizing: border-box; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: start; widows: 2; word-spacing: 0px;">After reading these articles, you should be able to…</em></p><br>]]>
      </description>
      <pubDate>Wed, 01 Apr 2026 01:23:53 -0400</pubDate>
      <link>https://www.thecarlatreport.com/articles/5902-copy-of-learning-objectives-adhd-tcpr-march-2026</link>
      <guid>http://www.thecarlatreport.com/articles/5902</guid>
    </item>
    <item>
      <title>Learning Objectives, Drug Trends CATR, April/May/June 2026</title>
      <description>
        <![CDATA[<p><em>After reading these articles,&nbsp;you should be able to…</em></p>]]>
      </description>
      <pubDate>Wed, 01 Apr 2026 01:00:00 -0400</pubDate>
      <link>https://www.thecarlatreport.com/articles/5923-learning-objectives-outpatient-treatment-of-substance-use-disorder-catr-january-february-march-2026</link>
      <guid>http://www.thecarlatreport.com/articles/5923</guid>
    </item>
    <item>
      <title>Learning Objectives, Workplace Violence Prediction &amp; Prevention, CHPR, April/May/June 2026</title>
      <description>
        <![CDATA[<p>After reading these articles,&nbsp;you should be able to…</p>]]>
      </description>
      <pubDate>Wed, 01 Apr 2026 01:00:00 -0400</pubDate>
      <link>https://www.thecarlatreport.com/articles/5912-learning-objectives-workplace-violence-prediction-and-prevention-chpr-april-may-june-2026</link>
      <guid>http://www.thecarlatreport.com/articles/5912</guid>
    </item>
    <item>
      <title>CME Post-Test, Drug Trends, CATR, April/May/June 2026</title>
      <description>
        <![CDATA[<p>By successfully completing the test you will be awarded a certificate for 2 CME credits.</p>]]>
      </description>
      <pubDate>Wed, 01 Apr 2026 01:00:00 -0400</pubDate>
      <link>https://www.thecarlatreport.com/articles/5913-copy-of-cme-post-test-outpatient-treatment-of-substance-use-disorder-catr-january-february-march-2026</link>
      <guid>http://www.thecarlatreport.com/articles/5913</guid>
    </item>
    <item>
      <title>CME Post-Test, Workplace Violence Prediction &amp; Prevention, April/May/June 2026</title>
      <description>
        <![CDATA[<p>By successfully completing the test you will be awarded a certificate for 2 CME credit.</p>]]>
      </description>
      <pubDate>Wed, 01 Apr 2026 01:00:00 -0400</pubDate>
      <link>https://www.thecarlatreport.com/articles/5905-cme-post-test-workplace-violence-prediction-and-prevention-april-may-june-2026</link>
      <guid>http://www.thecarlatreport.com/articles/5905</guid>
    </item>
    <item>
      <title>CME Post-Test, PTSD, TCPR, April 2026</title>
      <description>
        <![CDATA[<p>By successfully completing the test you will be awarded a certificate for 1 CME credit.</p>]]>
      </description>
      <pubDate>Wed, 01 Apr 2026 01:00:00 -0400</pubDate>
      <link>https://www.thecarlatreport.com/articles/5896-cme-post-test-ptsd-tcpr-april-2026</link>
      <guid>http://www.thecarlatreport.com/articles/5896</guid>
    </item>
    <item>
      <title>Prescription Drug Misuse and Diversion in Correctional Settings</title>
      <description>
        <![CDATA[<p>Medication misuse in correctional settings reveals how prescribing practices intersect with diversion risk. Dr. Holoyda discusses high demand agents such as gabapentin and bupropion, system level strategies like crush and float, and how to balance safety with adequate treatment. The lessons extend beyond jails to hospitals and outpatient units.</p>]]>
      </description>
      <pubDate>Wed, 01 Apr 2026 00:00:08 -0400</pubDate>
      <link>https://www.thecarlatreport.com/articles/5919-prescription-drug-misuse-and-diversion-in-correctional-settings</link>
      <guid>http://www.thecarlatreport.com/articles/5919</guid>
    </item>
    <item>
      <title>What Psychiatrists Should Know About Inhalants</title>
      <description>
        <![CDATA[<p>Inhalant misuse is often missed in routine practice, especially when drug screens are negative. This update reviews common products, acute risks such as sudden sniffing death, long-term neurologic injury, and nitrous oxide related B12 deficiency. Learn practical screening questions, red flags, and management strategies relevant to both adolescents and adults.</p>]]>
      </description>
      <pubDate>Wed, 01 Apr 2026 00:00:00 -0400</pubDate>
      <link>https://www.thecarlatreport.com/articles/5922-what-psychiatrists-should-know-about-inhalants</link>
      <guid>http://www.thecarlatreport.com/articles/5922</guid>
      <enclosure url="https://www.thecarlatreport.com/ext/resources/2026/04/09/CATR_AprMayJun2026.webp?t=1775762177" type="image/jpeg" length="90107"/>
    </item>
  </channel>
</rss>
